Synlett 2001; 2001(6): 0842-0844
DOI: 10.1055/s-2001-14609
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Nucleophilic Functionalization of Benzylidene Dihydrothiazole through DDQ-Promoted Formation of an Original Ambivalent Electrophilic Intermediate

Cécile Vanier* , Alain Wagner, Charles Mioskowski
  • *Laboratoire de Synthèse Bio-organique, Université Louis Pasteur de Strasbourg, UMR 7514 associée au CNRS, Faculté de Pharmacie, 74 route du Rhin - B.P. 24 - 67401 Illkirch cedex, France; Fax + 3 33 90 24 43 06; E-mail: mioskow@aspirine.u-strasbg.fr; alwag@aspirine.u-strasbg.fr
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Benzylidene dihydrothiazoles undergo DDQ-promoted hydrogen abstraction to yield an original ambivalent electrophilic intermediate. Treated with nucleophiles this covalent intermediate undergoes two possible substitution reactions one at the 5-methyl position and one at the DDHQ aromatic center. For a given benzylidene dihydrothiazole the ratio of the two products depends on the nature of the nucleophile.